Stuart Therapeutics Announces Initial Results of Phase III Clinical Trial for ST-100 (Vezocolmitide) Ophthalmic Solution, a Novel Dry Eye Disease Candidate PR Newswire STUART, Fla., June 24, 2025 ...

Stuart Therapeutics is finalizing a plan for an additional clinical trial using the results from the present Phase III trial to help guide the trial design. The Company also intends to engage with the ...